NxStage Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

NXTM 16.62 -0.75 (-4.32%)
price chart
NxStage Medical, Inc. Analyst Rating Update
NxStage Medical, Inc. (NASDAQ:NXTM) has received a short term rating of buy from research analysts at Zacks with a rank of 2. The company has been rated an average of 2 by 6 Wall Street Analysts.
Company Shares of NxStage Medical, Inc. (NASDAQ:NXTM) Drops by -4.62%
NxStage Medical, Inc. (NASDAQ:NXTM) has dropped 4.62% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 21.36% in the last 4 weeks.
Nxstage Medical, Inc. (NXTM) Discloses SEC Form 4 Insider Selling : Joseph E ...  Money Flow Index
Insider Trading: Joseph Turk Unloaded 2000 Shares of NxStage Medical, Inc ...  OctaFinance.com
Large Outflow of Money Witnessed in NxStage Medical, Inc.
NxStage Medical, Inc. (NASDAQ:NXTM) surged 2.31% during the last session. The last traded price was up 0.41 points at $18.17.
Nxstage Medical, Inc. (NXTM) Discloses Form 4 Insider Selling : Exec. Robert ...  American Trade Journal
Shares of NxStage Medical, Inc. (NASDAQ:NXTM) Drops by -0.55%  OTC Outlook
NxStage Medical, Inc. Short Interest Update
NxStage Medical, Inc. (NASDAQ:NXTM), According to the latest information the short interest in NxStage Medical, Inc. plummeted by 20.4% or 1,037,184 shares. The final shorts are 6.8% of the total floated shares. The positions dropped from 5,074,508 ...
NxStage Medical, Inc. (NASDAQ:NXTM) Stock Rating Update  Investor Newswire
NxStage Medical, Inc. (NASDAQ:NXTM) Given $15-$24 PT Range  Markets Daily
Nxstage Medical, Inc. (NXTM) Discloses Form 4 Insider Selling : Exec. Winifred ...
Nxstage Medical, Inc. (NXTM) Discloses Insider Transaction. Winifred L Swan , SVP and General Counsel of Nxstage Medical, Inc. sold 2,500 shares on Aug 14, 2015. The Insider selling transaction was disclosed on Aug 17, 2015 to the Securities and ...
NxStage Medical, Inc. Price Target Update  OTC Outlook
Insider Selling: NxStage Medical insider Sells $198097.50 in Stock (NXTM)  The Legacy
Form 8-K NxStage Medical, Inc. For: Aug 06
Net loss attributable to NxStage Medical, Inc.'s stockholders improved to $5.3 million for the second quarter of 2015 compared with a net loss of $7.1 million for the second quarter of 2014.
Analyst Rating Update on NxStage Medical, Inc.  Insider Trading Report
Nxstage Medical, Inc. (NXTM) Discloses SEC Form 4 Insider Selling : Joseph E ...  Money Flow Index
NxStage Medical, Inc. (NASDAQ:NXTM)'s Stock Insider Deal - Robert Brown Sold ...
The President - NxStage Kidney Care of NxStage Medical, Inc. (NASDAQ:NXTM) 17.33 -0.37 -2.09% and corporation's insider Robert Brown unloaded 10,825 shares of the public firm based on the price of stock which is $18.3 for share.
Nxstage Medical, Inc. (NXTM) Files Form 4 Insider Selling : Robert S. Brown ...  Insider Trading Report
Joseph Turk just Unloaded 2500 shares of NxStage Medical, Inc. (NASDAQ:NXTM ...
Joseph Turk, President of NxStage Medical, Inc. (NASDAQ:NXTM) 18.32 -0.03 -0.16% is the insider, our financial writers want to disclose transactions for.
Shares of NxStage Medical, Inc. (NASDAQ:NXTM) Rally 25.98%  News Watch International
NxStage Medical Earns Buy Rating from Canaccord Genuity (NXTM)  The Legacy
Jeffrey Burbank Sold $180300 Worth of NxStage Medical, Inc. (NASDAQ:NXTM) Shares
Jeffrey Burbank, the well informed person, who is at present the Chief Executive Officer of NxStage Medical, Inc. (NASDAQ:NXTM) 17.26 -0.44 -2.46% unloaded precisely 10,000 shares of the firm with a market value $180,300 US Dollars based on a market ...
Nxstage Medical, Inc. (NXTM) Files Form 4 Insider Selling : Joseph E Jr Turk ...  Insider Trading Report
Brokerage Views on NxStage Medical, Inc. (NASDAQ:NXTM)  Markets Daily
Jeffrey Burbank Sold $311200 Worth of NxStage Medical, Inc. (NASDAQ:NXTM) Stock
The Chief Executive Officer of NxStage Medical, Inc. (NASDAQ:NXTM) 17.33 -0.37 -2.09% and company's insider Jeffrey Burbank made a sale of 20,000 shares of the stock exchange listed company calculated based on the stock price per share of $15.6 per ...